Arterra Bioscience SpA ( (IT:ARBS) ) just unveiled an announcement.
Arterra Bioscience S.p.A. reported a significant revenue increase of 21.6% for the first quarter of 2025, reaching approximately 1.3 million Euros. This growth, driven by sales of cosmetic raw materials, underscores the company’s positive trajectory and confidence in meeting future objectives, reinforcing its strong position in the biotechnology sector.
More about Arterra Bioscience SpA
Arterra Bioscience S.p.A. is an Italian green biotech company specializing in research and development in biotechnology. Listed on the Euronext Growth Milan market since 2019, the company focuses on developing products and processes using living organisms for applications in cosmetics, agriculture, and nutraceuticals. Founded in 2004 by Gabriella Colucci, Arterra has established collaborations with companies and research institutes globally, including a joint venture with Intercos S.p.A. for innovative skincare products.
YTD Price Performance: 14.29%
Average Trading Volume: 13,067
Technical Sentiment Signal: Sell
Current Market Cap: €15.71M
Find detailed analytics on ARBS stock on TipRanks’ Stock Analysis page.